EVH — Evolent Health Income Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousLarge CapNeutral

Annual income statement for Evolent Health, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	R2019 December 31st	C2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	687	925	908	1,352	1,964
Cost of Revenue
Gross Profit	174	228	250	317	460
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	996	1,239	926	1,359	2,056
Operating Profit	-309	-315	-17.8	-6.55	-92.2
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-330	-331	-29.8	-62.1	-202
Provision for Income Taxes
Net Income After Taxes	-307	-328	-30.3	-18.7	-113
Minority Interest
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	-302	-334	-37.6	-19.2	-113
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-302	-334	-37.6	-19.2	-142
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-1.96	-1.72	-0.449	0.044	-0.665